Efficacy of cyclooxygenase-2–specific inhibitors
- 19 February 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (3), 6-12
- https://doi.org/10.1016/s0002-9343(00)00681-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- COX-2 inhibitorsThe Lancet, 1999
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Biology and toxic effects of nonsteroidal anti-inflammatory drugsCurrent Opinion in Rheumatology, 1998
- Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory DrugsThe American Journal of Medicine, 1998
- Mechanism of Action of Nonsteroidal Anti-inflammatory DrugsThe American Journal of Medicine, 1998
- Mechanism of action of aspirin-like drugsSeminars in Arthritis and Rheumatism, 1997
- Differentiating among nonsteroidal antiinflammatory drugsby pharmacokinetic and pharmacodynamic profilesSeminars in Arthritis and Rheumatism, 1997
- Cyclo-Oxygenase IsoenzymesDrugs, 1997
- A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymesTrends in Pharmacological Sciences, 1997
- Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor modelsThe American Journal of Medicine, 1991